<SEC-DOCUMENT>0000950170-25-050587-index.html : 20250403
<SEC-HEADER>0000950170-25-050587.hdr.sgml : 20250403
<ACCEPTANCE-DATETIME>20250403171536
ACCESSION NUMBER:		0000950170-25-050587
CONFORMED SUBMISSION TYPE:	S-8
PUBLIC DOCUMENT COUNT:		6
FILED AS OF DATE:		20250403
DATE AS OF CHANGE:		20250403
EFFECTIVENESS DATE:		20250403

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			SAB Biotherapeutics, Inc.
		CENTRAL INDEX KEY:			0001833214
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				853899721
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		S-8
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-286368
		FILM NUMBER:		25810728

	BUSINESS ADDRESS:	
		STREET 1:		777 W 41ST ST
		STREET 2:		SUITE 401
		CITY:			MIAMI BEACH
		STATE:			FL
		ZIP:			33140
		BUSINESS PHONE:		305-845-2813

	MAIL ADDRESS:	
		STREET 1:		777 W 41ST ST
		STREET 2:		SUITE 401
		CITY:			MIAMI BEACH
		STATE:			FL
		ZIP:			33140

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Big Cypress Acquisition Corp.
		DATE OF NAME CHANGE:	20201120
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-8
<SEQUENCE>1
<FILENAME>sabs_s-8_fy25apr.htm
<DESCRIPTION>S-8
<TEXT>
Document 1 - file: sabs_s-8_fy25apr.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>2
<FILENAME>sabs-ex5_1.htm
<DESCRIPTION>EX-5.1
<TEXT>
Document 2 - file: sabs-ex5_1.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>3
<FILENAME>sabs-ex23_1.htm
<DESCRIPTION>EX-23.1
<TEXT>
Document 3 - file: sabs-ex23_1.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-FILING FEES
<SEQUENCE>4
<FILENAME>sabs-exfiling_fees.htm
<DESCRIPTION>EX-FILING FEES
<TEXT>
Document 4 - file: sabs-exfiling_fees.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>img84541401_0.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 5 - file: img84541401_0.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>img84541401_1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 6 - file: img84541401_1.jpg

</DOCUMENT>
</SEC-DOCUMENT>